Confluent Medical Technologies: Company Market Research Report

Company Overview

Name and Mission

Name: Confluent Medical Technologies

Mission: Dedicated to being the most trusted partner in the medical device industry by upholding integrity, exceptional quality, and operational excellence. Confluent focuses on providing life-improving solutions through growth, leadership, and innovation.

Founding and Key People

Founded: Originally in 1991 as Nitinol Device and Components (NDC).

Founders: No specific founders mentioned, but became NDC again post J&J Spinoff.

Key People:

Dean Schauer - Director, CEO & President, appointed Chairman as of September 10, 2024.

Doug Hutchison - Chief Commercial Officer

Matt Eckl - Chief Financial Officer

Brian Adcock - Chief Human Resources Officer

Richard Brown - SVP, Quality Assurance & Regulatory Affairs

David Johnston - SVP, Multi-Site Operations

Jim Hillman - SVP, Multi-Site Operations

Headquarters and Operations

Headquarters Locations: Facilities in Fremont and Orange County, California; Warwick, Rhode Island; Windham, Maine; Austin, Texas; Chattanooga, Tennessee; as well as international operations in Costa Rica and India.

Number of Employees: Over 2,000 employees.

Notable Characteristics: Known for its expertise in materials science, particularly in Nitinol, and complex manufacturing within the med-tech sector.

Revenue

Revenue: Specific revenue figures are not available. However, under CEO Dean Schauer, Confluent was recognized for revenue growth.

Key Expertise

Known for pioneering the application of Nitinol in medical devices, complex catheters, and high-precision polymer tubing, specializing in catheter-based devices and implants.

Products

Overview of Products

Confluent offers a diverse range of products rooted in materials science tailored for medical applications:

1. Nitinol Components: High-precision components and tubing, known for rapid prototyping and unique laser-cut designs.

2. Polymer Tubing:

PTFE: Offers flexibility, thin walls, and comes in various sizes.

Polyimide: Known for strength, stiffness, and dielectric properties.

Braid and coil reinforcement options for performance enhancement.

3. Biomedical Textiles: Woven, knit, braid, and non-woven textiles for medical applications, especially cardiovascular.

4. Complex Catheters:

Steerable guide & ablation catheters.

Capability to integrate flexible circuit technology.

Offers rapid prototyping to meet client specifications swiftly.

Key Features of Selected Products

Nitinol Tubing and Wire: Offers SE508 & SE508 ELI, promising high fatigue application suitability such as cardiovascular implants.

Polymer Tubing: Known for precise wall thickness and diverse material options to meet industry-specific demands.

Biomedical Textiles: Includes bespoke textile properties with opportunities for occluders, heart valves, and stent grafts through Electrospinning technology.

Recent Developments

Recent Events and Innovations

Chairman Appointment: Dean Schauer was appointed Chairman of the Board in September 2024, marking a new phase in leadership focus.

Board Additions: In March 2024, Sandy Stojkovski and Brian Yoor joined the Board of Directors, bringing valuable operational and financial expertise.

Investment in Nitinol Production: January 2024 marked a $50 million investment in partnership with ATI, aimed at expanding Nitinol melt and conversion capacity, expecting completion in 2027.

New Products and Features

New Polymer Webshop launched to address supply constraints in PTFE.

Partnerships

ATI Partnership: Confluent became a fulfillment partner for ATI's medical Nitinol operations post-significant investment to enhance supply capacity.

By aligning capabilities with customer needs and continuing investments in new materials science expansions, Confluent Medical Technologies reinforces its position as a leader in the medical device manufacturing industry.